Hereditary hemorrhagic telangiectasia (HHT) is a relatively common autosomal dominant condition. Epistaxis is a frequent manifestation, often occurring daily and requiring iron and blood transfusions. Surgery often is bloody and difficult. The aim of this study was to evaluate the effectiveness of a sprayed fibrin, hemostatic sealant in preventing postoperative epistaxis after laser treatment of nasal mucosa in HHT. Fibrin sealant was compared with nasal packing for likelihood of postoperative epistaxis and financial impact including material costs and hospitalization fees.
Methods
Retrospective review was performed of 64 individual laser treatments for epistaxis in HHT patients at the University of California, San Diego, Medical Center between 2002 and 2005. Nasal packing was used in 30 procedures and fibrin sealant was used in 34 procedures.
Results
Six of 30 (20%) procedures using postoperative nasal packing required admission with an average hospital expense of $5914. One of 34 patients (3%) in the fibrin sealant group required hospitalization (p = 0.04).
Conclusion
Aerosolized fibrin sealant prevents postoperative epistaxis after nasal laser treatment in HHT patients. Compared with traditional nasal packing we found improved patient comfort and recovery with substantial cost savings.
WestermannC.J., RosinaA.F., De VriesV., and de CoteauP.A.The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: A family screening.Am J Med Genet A116: 324–328, 2003.
2.
PorteousM.E., BurnJ., and ProctorS.J.Hereditary haemorrhagic telangiectasia: A clinical analysis.J Med Genet29: 527–530, 1992.
3.
BergJ., PorteousM., ReinhardtD.Hereditary haemorrhagic telangiectasia: A questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.J Med Genet40: 585–590, 2003.
4.
CirulliA., LisoA., D'OvidioF.Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia.Acta Haematol110: 29–32, 2003.
LundV.J., and HowardD.J.A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia.Am J Rhinol13: 319–322, 1999.
10.
ByahattiS.V., RebeizE.E., and ShapshayS.M.Hereditary hemorrhagic telangiectasia: What the otolaryngologist should know.Am J Rhinol11: 55–62, 1997.
11.
KlugerP.B., ShapshayS.M., HybelsR.L., and BohigianR.K.Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: An update report.Laryngoscope97: 1397–1401, 1987.
12.
FlessaH.C., and GlueckH.I.Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Management of epistaxis in nine patients using systemic hormone therapy.Arch Otolaryngol103: 148–151, 1977.
13.
MehtaA.C., LivingstonD.R., and LevineH.L.Fiberoptic bronchoscope and Nd-YAG laser in treatment of severe epistaxis from nasal hereditary hemorrhagic telangectasia and hem-angioma.Chest91: 791–792, 1987.
14.
VaimanM., EviatarE., ShlamkovichN., and SegalS.Effect of modern fibrin glue on bleeding after tonsillectomy and adenoidectomy.Ann Otol Rhinol Laryngol112: 410–414, 2003.
15.
VaimanM., EviatarE., and SegalS.The use of fibrin glue as hemostatic in endonasal operations: A prospective, randomized study.Rhinology40: 185–188, 2002.
16.
VaimanM., EviatarE., and SegalS.Effectiveness of second-generation fibrin glue in endonasal operations.Otolaryngol Head Neck Surg126: 388–391, 2002.
17.
VaimanM., EviatarE., ShlamkovichN., and SegalS.Use of fibrin glue as a hemostatic in endoscopic sinus surgery.Ann Otol Rhinol Laryngol114: 237–241, 2005.
18.
VaimanM., SarfatyS., ShlamkovichN.Fibrin sealant: Alternative to nasal packing in endonasal operations. A prospective randomized study.Isr Med Assoc J7: 571–574, 2005.
19.
VaimanM., MartinovichU., EviatarE.Fibrin glue in initial treatment of epistaxis in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease).Blood Coagul Fibrinolysis15: 359–363, 2004.
20.
NanthakumarK., GrahamA.T., RobinsonT.I.Contrast echocardiography for detection of pulmonary arteriovenous malformations.Am Heart J141: 243–246, 2001.
21.
FulbrightR.K., ChaloupkaJ.C., PutmanC.M.MR of hereditary hemorrhagic telangiectasia: Prevalence and spectrum of cerebrovascular malformations.AJNR Am J Neuroradiol19: 477–484, 1998.
22.
KjeldsenA.D., and KjeldsenJ.Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.Am J Gastroenterol95: 415–418, 2000.
23.
SharmaV.K., and HowdenC.W.Gastrointestinal and hepatic manifestations of hereditary hemorrhagic telangiectasia.Dig Dis16: 169–174, 1998.
24.
ShahR.K., DhingraJ.K., and ShapshayS.M.Hereditary hemorrhagic telangiectasia: A review of 76 cases.Laryngoscope112: 767–773, 2002.
25.
MahoneyE.J., and ShapshayS.M.Nd-YAG laser photocoagulation for epistaxis associated with hereditary hemorrhagic telangiectasia.Laryngoscope115: 373–375, 2005.
26.
BerglerW., RiedelF., Baker-SchreyerA.Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia.Laryngoscope109: 15–20, 1999.
27.
TierneyP.A., SamuelD., PatelK.S., and ThomasD.M.Audit of patient acceptance of nasal surgery as a day case procedure.Br J Clin Pract50: 357–359, 1996.
28.
WeberR., HochapfelF., and DrafW.Packing and stents in endonasal surgery.Rhinology38: 49–62, 2000.
KalogjeraL., PeganB., and PetricV.Adaptation to oral breathing after anterior nasal packing.Acta Otolaryngol115: 304–306, 1995.
31.
JohannessenN., JensenP.F., KristensenS., and JuulA.Nasal packing and nocturnal oxygen desaturation.Acta Otolaryngol Suppl492: 6–8, 1992.
32.
ScheuleA.M., BeierleinW., WendelH.P.Aprotinin in fibrin tissue adhesives induces specific antibody response and increases antibody response of high-dose intravenous application.J Thorac Cardiovasc Surg118: 348–353, 1999.
33.
DietrichW., SpathP., ZuhlsdorfM.Anaphylactic reactions to aprotinin reexposure in cardiac surgery: Relation to antiaprotinin immunoglobulin G and E antibodies.Anesthesiology95: 64–71, 65A–66A, 2001.
34.
OswaldA.M., JolyL.M., GuryC.Fatal intraoperative anaphylaxis related to aprotinin after local application of fibrin glue.Anesthesiology99: 762–763, 2003.
35.
BeierleinW., ScheuleA.M., DietrichW., and ZiemerG.Forty years of clinical aprotinin use: A review of 124 hypersensitivity reactions.Ann Thorac Surg79: 741–748, 2005.
